The store will not work correctly when cookies are disabled.
N,N-dimethyl-2-(6-(5-methylthiophen-2-yl)-1H-pyrrolo[3,2-b]pyridin-1-yl)acetamide
ID: ALA4575739
PubChem CID: 124176242
Max Phase: Preclinical
Molecular Formula: C16H17N3OS
Molecular Weight: 299.40
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ccc(-c2cnc3ccn(CC(=O)N(C)C)c3c2)s1
Standard InChI: InChI=1S/C16H17N3OS/c1-11-4-5-15(21-11)12-8-14-13(17-9-12)6-7-19(14)10-16(20)18(2)3/h4-9H,10H2,1-3H3
Standard InChI Key: QLVPQOVZXHEIDR-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
16.4992 -16.6987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4981 -17.5183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2061 -17.9272 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2044 -16.2899 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.9130 -16.6951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9178 -17.5137 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6978 -17.7622 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.1752 -17.0971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6900 -16.4377 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9548 -18.5379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7551 -18.7032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0122 -19.4789 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.2984 -18.0927 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.4689 -20.0893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8125 -19.6441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7901 -17.9263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0423 -17.5948 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
14.4950 -18.2016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9031 -18.9097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7025 -18.7403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6824 -18.1156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
7 10 1 0
10 11 1 0
11 12 1 0
11 13 2 0
12 14 1 0
12 15 1 0
2 16 1 0
16 17 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 16 2 0
18 21 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 299.40 | Molecular Weight (Monoisotopic): 299.1092 | AlogP: 3.16 | #Rotatable Bonds: 3 |
Polar Surface Area: 38.13 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.07 | CX LogP: 2.65 | CX LogD: 2.65 |
Aromatic Rings: 3 | Heavy Atoms: 21 | QED Weighted: 0.74 | Np Likeness Score: -2.09 |
References
1. Chrovian CC, Soyode-Johnson A, Wall JL, Rech JC, Schoellerman J, Lord B, Coe KJ, Carruthers NI, Nguyen L, Jiang X, Koudriakova T, Balana B, Letavic MA.. (2019) 1H-Pyrrolo[3,2-b]pyridine GluN2B-Selective Negative Allosteric Modulators., 10 (3): [PMID:30891123] [10.1021/acsmedchemlett.8b00542] |